stars 1 stars 2 stars 3

Longevity Biotech is developing new therapeutic drug candidates, which may have direct clinical impacts on patients lives. All of our programs are based on our Hybridtide peptide scaffold technology. Hybridtides are designed for long-acting oral administration.

Longevity Biotech Questions

The Longevity Biotech annual revenue was $1 million in 2026.

Scott Shandler is the Founder and CEO of Longevity Biotech.

1 people are employed at Longevity Biotech.

Longevity Biotech is based in Philadelphia, Pennsylvania.

The NAICS codes for Longevity Biotech are [541714, 5417, 54171, 54, 541].

The SIC codes for Longevity Biotech are [873, 87].

Top Longevity Biotech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users